JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2701
CALL
Crocs
CROX
$5.76B
| $7.1M | ﹤0.01% |
49,400
-68,600
| -58% | -$7.82M |
2022 Q3
6 quarters
|
|
2702
iShares Russell Top 200 Growth ETF
IWY
$16.9B
| $7.07M | ﹤0.01% |
36,241
-1,033
| -3% | -$193K |
2019 Q3
18 quarters
|
|
2703
Invesco S&P 500 High Beta ETF
SPHB
$989M
| $7.06M | ﹤0.01% |
80,503
+60,147
| +295% | +$4.98M |
2022 Q1
8 quarters
|
|
2704
CALL
Cigna
CI
$72.5B
| $7.05M | ﹤0.01% |
19,400
+17,400
| +870% | +$5.73M |
2021 Q2
11 quarters
|
|
2705
Capital Group Dividend Value ETF
CGDV
$39.2B
| $7.04M | ﹤0.01% |
216,597
+60,800
| +39% | +$1.87M |
2023 Q1
4 quarters
|
|
2706
CALL
NXP Semiconductors
NXPI
$61.6B
| $7.04M | ﹤0.01% |
28,400
-40,600
| -59% | -$9.38M |
2023 Q2
3 quarters
|
|
|
SMC
2707
Summit Midstream
SMC
$457M
| $7.03M | ﹤0.01% |
250,453
-30,361
| -11% | -$567K |
2021 Q1
12 quarters
|
|
|
GRFS
2708
Grifois
GRFS
$5.12B
| $7.03M | ﹤0.01% |
1,052,275
-841,504
| -44% | -$6.57M |
2013 Q2
43 quarters
|
|
2709
PUT
PayPal
PYPL
$46.7B
| $7.01M | ﹤0.01% |
104,700
-230,300
| -69% | -$14.1M |
2015 Q3
34 quarters
|
|
2710
CALL
Suncor Energy
SU
$79.8B
| $7.01M | ﹤0.01% |
+189,900
| New | +$6.39M |
2024 Q1
0 quarters
|
|
2711
PUT
Union Pacific
UNP
$164B
| $7.01M | ﹤0.01% |
28,500
-82,100
| -74% | -$20.2M |
2014 Q3
38 quarters
|
|
2712
News Corp Class B
NWS
$17B
| $7.01M | ﹤0.01% |
258,871
+19,510
| +8% | +$516K |
2015 Q3
34 quarters
|
|
2713
Invesco Preferred ETF
PGX
$3.6B
| $6.96M | ﹤0.01% |
585,582
-937,880
| -62% | -$11.1M |
2014 Q4
37 quarters
|
|
2714
CALL
Gilead Sciences
GILD
$179B
| $6.94M | ﹤0.01% |
94,800
-39,400
| -29% | -$3.03M |
2014 Q3
38 quarters
|
|
|
LEG
2715
DELISTED
Leggett & Platt
LEG
| $6.94M | ﹤0.01% |
362,326
-42,965
| -11% | -$934K |
2013 Q2
43 quarters
|
|
2716
PUT
Revvity
RVTY
$17.1B
| $6.92M | ﹤0.01% |
65,900
+35,900
| +120% | +$3.82M |
2023 Q4
1 quarter
|
|
2717
Outset Medical
OM
$77.8M
| $6.91M | ﹤0.01% |
207,647
-123,100
| -37% | -$6.23M |
2020 Q3
14 quarters
|
|
2718
Burford Capital
BUR
$795M
| $6.91M | ﹤0.01% |
432,568
-400,010
| -48% | -$5.93M |
2020 Q4
13 quarters
|
|
2719
AXIS Capital
AXS
$7.02B
| $6.89M | ﹤0.01% |
105,988
-2,206
| -2% | -$132K |
2013 Q2
43 quarters
|
|
2720
Annexon
ANNX
$764M
| $6.88M | ﹤0.01% |
959,648
+930,063
| +3,144% | +$4.83M |
2020 Q3
14 quarters
|
|
2721
CALL
Dow Inc
DOW
$20.3B
| $6.88M | ﹤0.01% |
118,700
-315,800
| -73% | -$17.5M |
2020 Q4
13 quarters
|
|
2722
Protagonist Therapeutics
PTGX
$8.97B
| $6.87M | ﹤0.01% |
237,440
-173,606
| -42% | -$4.72M |
2017 Q4
25 quarters
|
|
2723
Titan Machinery
TITN
$593M
| $6.87M | ﹤0.01% |
276,817
+69,412
| +33% | +$1.81M |
2015 Q4
33 quarters
|
|
2724
Privia Health
PRVA
$2.59B
| $6.87M | ﹤0.01% |
350,542
+99,110
| +39% | +$2.09M |
2021 Q2
11 quarters
|
|
2725
Camden National
CAC
$959M
| $6.85M | ﹤0.01% |
204,427
+67,332
| +49% | +$2.28M |
2017 Q4
25 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.